[go: up one dir, main page]

MX2018008837A - Oligosacaridos de leche humana contra la acumulacion de masa grasa excesiva y trastornos de la salud conexos mas adelante en la vida. - Google Patents

Oligosacaridos de leche humana contra la acumulacion de masa grasa excesiva y trastornos de la salud conexos mas adelante en la vida.

Info

Publication number
MX2018008837A
MX2018008837A MX2018008837A MX2018008837A MX2018008837A MX 2018008837 A MX2018008837 A MX 2018008837A MX 2018008837 A MX2018008837 A MX 2018008837A MX 2018008837 A MX2018008837 A MX 2018008837A MX 2018008837 A MX2018008837 A MX 2018008837A
Authority
MX
Mexico
Prior art keywords
life
accumulation
fat mass
oligosacarids
human milk
Prior art date
Application number
MX2018008837A
Other languages
English (en)
Other versions
MX381980B (es
Inventor
Sprenger Norbert
BINIA Aristea
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018008837A publication Critical patent/MX2018008837A/es
Publication of MX381980B publication Critical patent/MX381980B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/206—Bacterial extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides
    • A23V2250/284—Oligosaccharides, non digestible
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/50—Polysaccharides, gums
    • A23V2250/502—Gums
    • A23V2250/5062—Inulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5438—Sialic acid, glycomacroprotein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/61—Glucose, Dextrose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/612—Lactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una composición nutritiva que comprende al menos un oligosacárido fucosilado para usar en un infante o niño pequeño para reducir y/o prevenir una acumulación excesiva de masa grasa y/o un trastorno de la salud relacionado con una acumulación excesiva de masa grasa más adelante en la vida, en donde dicho oligosacárido fucosilado tiene al menos un grupo de fucosa unido por un enlace alfa 1,3, al menos un grupo de fucosa unido por un enlace alfa 1,4, o combinaciones de estos. La invención se refiere además a una composición nutritiva para usar para promover el crecimiento saludable.
MX2018008837A 2016-01-26 2017-01-26 Oligosacáridos de leche humana contra la acumulación de masa grasa excesiva y trastornos de la salud conexos más adelante en la vida. MX381980B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16152734 2016-01-26
PCT/EP2017/051587 WO2017129646A1 (en) 2016-01-26 2017-01-26 Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders

Publications (2)

Publication Number Publication Date
MX2018008837A true MX2018008837A (es) 2018-09-21
MX381980B MX381980B (es) 2025-03-13

Family

ID=55237541

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008837A MX381980B (es) 2016-01-26 2017-01-26 Oligosacáridos de leche humana contra la acumulación de masa grasa excesiva y trastornos de la salud conexos más adelante en la vida.

Country Status (7)

Country Link
US (1) US11229231B2 (es)
EP (1) EP3407893A1 (es)
CN (2) CN119097632A (es)
AU (1) AU2017211270B2 (es)
MX (1) MX381980B (es)
PH (1) PH12018501297A1 (es)
WO (1) WO2017129646A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2731067C2 (ru) * 2015-03-05 2020-08-28 Сосьете Де Продюи Нестле С.А. Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста
CN108495636A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 通过预防过早肥胖反弹而对健康有益的人乳低聚糖
US20200281245A1 (en) * 2017-07-07 2020-09-10 Societe Des Products Nestle S.A Human milk fortifier
EP3648617A1 (en) * 2017-07-07 2020-05-13 Société des Produits Nestlé S.A. Human milk fortifier
GB2573538B (en) * 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
US20220273016A1 (en) * 2019-07-18 2022-09-01 The Regents Of The University Of California Human milk oligosaccharides for control of dietary response and metabolic phenotype
TW202233201A (zh) * 2020-12-16 2022-09-01 荷蘭商弗里斯蘭康必奶荷蘭有限公司 包含ＬＮＦＰ ＩＩＩ和ＬＳＴａ的合成組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
EP1926394B1 (en) 2005-02-21 2020-02-19 Société des Produits Nestlé S.A. Oligosaccharide mixture
MY166946A (en) 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
BR112013016914A2 (pt) * 2010-12-31 2019-09-24 Abbott Lab combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica
EP2526784A1 (en) 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
MY186314A (en) * 2016-01-26 2021-07-08 Nestle Sa Compositions comprising 2fl and lnnt to control food intake and growth in infants or young children

Also Published As

Publication number Publication date
RU2018130357A3 (es) 2020-07-16
AU2017211270B2 (en) 2022-12-08
EP3407893A1 (en) 2018-12-05
CN119097632A (zh) 2024-12-10
RU2018130357A (ru) 2020-02-27
WO2017129646A1 (en) 2017-08-03
MX381980B (es) 2025-03-13
AU2017211270A1 (en) 2018-05-10
US20190029308A1 (en) 2019-01-31
CN108495635A (zh) 2018-09-04
US11229231B2 (en) 2022-01-25
PH12018501297A1 (en) 2019-01-28

Similar Documents

Publication Publication Date Title
MX2018008837A (es) Oligosacaridos de leche humana contra la acumulacion de masa grasa excesiva y trastornos de la salud conexos mas adelante en la vida.
MX2018009015A (es) Oligosacaridos de la leche humana para beneficios de la salud mediante la prevencion del rebote adiposo precoz.
CL2018001825A1 (es) Composiciones que comprenden 2fl y lnnt para usar en infantes o niños pequeños para prevenir la obesidad en la vida posterior o comorbilidades relacionadas
MX395055B (es) Composiciones con oligosacáridos específicos para prevenir la obesidad más adelante en la vida o comorbilidades relacionadas mediante el incremento de la producción colónica de scfa y/o el incremento de la secreción de glp-1.
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
PH12017500174A1 (en) INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs)
MX2016006060A (es) Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
MX2016006220A (es) Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea.
MX2018008954A (es) Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños.
AR100313A1 (es) Composiciones nutricionales dirigidas a sujetos con alergias a la proteína de la leche de vaca
ECSP17043318A (es) Composición que contiene quitina y proteínas digeribles
PH12018501263A1 (en) Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth
PH12018500992A1 (en) Nutritional compositions comprising a casein hydrolysate, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
MX385648B (es) Composiciones nutritivas y formulas infantiles que comprenden bifidobacterium animalis ssp.lactis y, opcionalmente, una mezcla de oligosacaridos para inducir una microbiota intestinal cercana a la de un infante alimentado por lactancia materna.
BR112018069682A2 (pt) métodos de tratamento para doenças colestáticas e fibróticas
CL2018000433A1 (es) Procedimientos para mejorar la salud de peces de cultivo.
ECSP13012799A (es) Uso de composiciones nutricionales que incluyen lactoferrinas para mejorar la resistencia a enfermedades y condiciones
BR112016017765A8 (pt) composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso
AR099863A1 (es) Método para reducir el riesgo de hipersensibilidad al dolor visceral
PH12020550653A1 (en) Synthetic nutritional compositions tailored for infants of specific ages, and nutritional systems comprising them
MX2020001840A (es) Administracion de vitamina b2 materna para la prevencion del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia.
MX391211B (es) Composiciones y metodos que usan il-8 para mejorar produccion de leche y salud reproductiva en mamiferos.
MX2015011388A (es) Induccion de una respuesta inmunitaria de proteccion en recien nacidos y lactantes por una unica dosis elevada de mva.
BR112019003928A2 (pt) fórmula para bebês alérgicos à proteína do leite de vaca